focus -WSS

focus

author：leisure time 2025-10-02 23:47:55 - browse：627

Sanofi CEO Paul Hudson Courtesy Sanofi

NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to fund more research studies of new medicines they say could one day generate billions of dollars in annual sales.

CEO Paul Hudson and Houman Ashrafian, Sanofi’s new head of R&D, made their remarks in an exclusive interview with STAT ahead of a full-day meeting with analysts here. When the cuts to earnings were first announced Oct. 27, along with a plan to spin off the company’s consumer products division, shares dove 18% and have yet to fully recover. The share price is down 5% since the beginning of 2023.

“I’ve been waiting four years for a situation where we could put [out] the pipeline, as impressive as it is, and declare that we’re going to be the world’s leading immunology company,” said Hudson, who took over as CEO in 2019. “So it’s quite an important moment for us. And it’s an important moment to declare that we’re back in science, because I could argue that we haven’t been where we needed to be.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

explore

WSS

Virginia high school admissions case could be legal follow

Guidelines to prevent youth baseball injuries need more muscle

Novavax promises a turnaround & Lilly roils the obesity market

Walensky prepares to leave CDC — and Congress — behind

United colonoscopy coverage change 'may cost lives,' doctors say

NFL doctors' conflicts of interest could endanger players, report says

focus

focus

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

State Dept. review finds Biden bears some blame for Afghanistan failures

How to save PrEP access — and even expand it

Bright Health sells Medicare Advantage business to Molina

Election results set back Medicaid expansion plans

Duchenne breakthrough therapy leaves behind pioneering families

In age of alternative facts, a scholarly course on calling out crap

Virginia high school admissions case could be legal follow

Pennsylvania man bitten on the head by bear during attack in his garage

entertainment

Trump used to be more articulate. What could explain the change?

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Continuity nursing helped my family in our darkest PICU moments

Slovenia has suffered its worst

Sweden knocks USA out of World Cup in penalty kicks

It was time to plan for my old age. If only I could stop crying

entertainment

explore

entertainment

Wikipedia